What is Trump's ‘most favored nation’ drug pricing policy and how will it reduce costs
Donald Trump on Sunday announced that he will be signing an executive order to reduce prescription drug prices in the US
President Donald Trump on Sunday announced that he will be signing an executive order to reduce prescription drug prices in the US. The 78-year-old mentioned his ‘Most Favored Nation’ (MFN) drug pricing policy, saying it will bring down prices by 30% to 80%.
“I will be instituting a MOST FAVORED NATION’S POLICY whereby the United States will pay the same price as the Nation that pays the lowest price anywhere in the World. Our Country will finally be treated fairly, and our citizens Healthcare Costs will be reduced by numbers never even thought of before,” Trump posted on Truth Social.
What is Trump's Most Favored Nation policy?
President Trump’s MFN drug pricing policy seeks to lower prescription drug costs in the United States by tying Medicare payments for certain drugs to the lowest prices paid by other high-income countries with comparable economies, such as Canada, Germany, or the United Kingdom.
Initially proposed during Trump’s first term in 2020, the policy was blocked by legal challenges from the pharmaceutical industry and rescinded by the Biden administration.
The MFN model caps Medicare payments for selected drugs at the lowest price available in a group of Organization for Economic Cooperation and Development (OECD) countries with similar per-capita GDP, adjusted for volume and purchasing power.
Trump explains his decision
Expanding on his decision, Donald Trump claimed that pharma companies in the US charge higher prices citing research and development costs.
“For many years the World has wondered why Prescription Drugs and Pharmaceuticals in the United States States of America were SO MUCH HIGHER IN PRICE THAN THEY WERE IN ANY OTHER NATION, SOMETIMES BEING FIVE TO TEN TIMES MORE EXPENSIVE THAN THE SAME DRUG, MANUFACTURED IN THE EXACT SAME LABORATORY OR PLANT, BY THE SAME COMPANY??? It was always difficult to explain and very embarrassing because, in fact, there was no correct or rightful answer,” he wrote.
ABOUT THE AUTHORYash Nitish BajajYash Bajaj is a Chief Content Producer with a strong foundation in US coverage, digital strategy, and audience-focused storytelling. As part of the US Desk at Hindustan Times, he covers a wide range of topics - from American politics to sports (NFL, NBA, derbies, MLB and more). Before joining Hindustan Times, Yash served as Deputy News Editor at Times Now, where he oversaw international coverage and led a team of six. In this role, he significantly expanded global traffic through strategic planning, SEO-driven content execution, and meticulous trend tracking across platforms. He is experienced in managing high-pressure breaking-news shifts, coordinating live coverage, and building newsroom systems that improve speed, accuracy, and reach. Prior to Times Now, Yash held a position at Opoyi, where he headed the Sports and US news team. He developed broad editorial strategies, guided reporters across multiple beats, and played a key role in recruiting and training new talent. His responsibilities also extended to social media management and experimenting with innovative content formats. A passionate NFL fan, Yash is a die-hard supporter of the Cincinnati Bengals and has followed Joe Burrow closely since his college days at LSU. Whether breaking down top players' latest performance, analyzing team performances, or tracking roster moves, he brings the same dedication and sharp storytelling to his sports coverage as he does to American politics and breaking news. When he’s not writing, Yash can often be found watching games or debating the latest NFL storylines with fellow fans. Yash holds a Bachelor of Mass Media (Journalism) from HR College, Mumbai University. His interests extend well beyond the newsroom: he is an enthusiastic explorer of AI tools, a movie buff with an ever-growing watchlist, and someone who enjoys unraveling conspiracy theories for fun.Read More

E-Paper


